GC Genome Corporation (KOSDAQ:340450)
9,000.00
-120.00 (-1.32%)
Jul 18, 2025, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 212.86 billion as of July 18, 2025.
Market Cap
212.86B
Enterprise Value
208.33B
Revenue
26.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,000.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 212.86B, a decrease of -18.92%. That is a compound annual growth rate of -87.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 18, 2025 | 212.86B | -1.32% |
Jul 17, 2025 | 215.70B | -0.22% |
Jul 16, 2025 | 216.17B | -0.87% |
Jul 15, 2025 | 218.06B | 3.36% |
Jul 14, 2025 | 210.97B | -3.25% |
Jul 11, 2025 | 218.06B | 4.77% |
Jul 10, 2025 | 208.13B | 0.80% |
Jul 9, 2025 | 206.47B | -0.11% |
Jul 8, 2025 | 206.71B | -1.35% |
Jul 7, 2025 | 209.55B | -1.56% |
Jul 4, 2025 | 212.86B | 2.62% |
Jul 3, 2025 | 207.42B | 0.57% |
Jul 2, 2025 | 206.23B | -3.43% |
Jul 1, 2025 | 213.57B | -0.22% |
Jun 30, 2025 | 214.04B | -2.69% |
Jun 27, 2025 | 219.95B | -3.93% |
Jun 26, 2025 | 228.94B | 3.86% |
Jun 25, 2025 | 220.43B | -3.12% |
Jun 24, 2025 | 227.52B | -1.84% |
Jun 23, 2025 | 231.78B | -3.26% |
Jun 20, 2025 | 239.58B | 8.23% |
Jun 19, 2025 | 221.37B | -1.47% |
Jun 18, 2025 | 224.68B | 2.15% |
Jun 17, 2025 | 219.95B | 0.22% |
Jun 16, 2025 | 219.48B | -5.50% |
Jun 13, 2025 | 232.25B | -9.16% |
Jun 12, 2025 | 255.67B | -2.61% |
Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.80T |
Celltrion | 39.82T |
ALTEOGEN | 26.19T |
Yuhan | 9,866.54B |
SK Biopharmaceuticals | 8,066.26B |
HLB Co., Ltd. | 6,939.04B |
Peptron | 6,861.07B |
PharmaResearch | 5,890.93B |